29 results
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
17 Dec 21
Entry into a Material Definitive Agreement
5:17pm
, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, “Hazardous Materials
8-K
EX-1.1
ONCT
Oncternal Therapeutics Inc
28 May 21
Entry into a Material Definitive Agreement
5:03pm
, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively, “Hazardous Materials”) or to the manufacture
8-K
EX-1.1
934v275d49n lsmu89
11 Dec 20
Oncternal Therapeutics Announces $40.0 Million Bought Deal Offering
6:11am
8-K
EX-1.1
yxcyq3nwqvs5t vra
19 Nov 20
Oncternal Therapeutics Announces $20.0 Million Bought Deal Offering
5:06pm
8-K
EX-1.1
cmy1j6hb jdumogds2f2
31 Aug 20
Oncternal Therapeutics Announces $3.5 Million Bought Deal Offering
4:33pm
8-K
EX-10.1
4wiw l9v2pp39k7b
21 Jul 20
Oncternal Therapeutics Announces $6.2 Million Registered Direct Offering
4:06pm
8-K
EX-10.1
00d1t3 z676cvgh
21 May 20
Oncternal Therapeutics Announces $5.0 Million Registered Direct Offering
4:31pm
424B3
mqx8xv1
8 May 19
Prospectus supplement
12:00am
S-4/A
rbd 09siid
3 May 19
Registration of securities issued in business combination transactions (amended)
9:51pm
S-4
EX-10.55
fag34jx
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
EX-10.54
35kann0vmj
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
S-4
kvzrlwv94kc9qoobfco
5 Apr 19
Registration of securities issued in business combination transactions
9:02pm
8-K
EX-2.1
kr5f6r5mjpbj6 cbc
7 Mar 19
Entry into a Material Definitive Agreement
7:33am